Knowledge Hub
Learn how we're pioneering a new wave of precision medicine, explore our collection of publications, disease studies, webinars, thought leadership, and more
Featured

COVID-19 disease study
Newsletter signup
Blog
Our Philosophy
A deep dive into our unique approach and our mission to find better treatment options for patients with unmet medical needs
Publication
Cell Patterns: INDX systematic indication extension
Paper demonstrating the potential of indication extension to systematically reposition hundreds of drugs into new indications
Disease Study
COVID-19 disease study
Understanding the disease biology of COVID-19 to find novel drug targets and new treatment options
Disease Study
Alzheimer's disease study
Reducing the risk of future Alzheimer's disease clinical trial failures by identifying patient subgroups
Webinar
Disease mechanisms and novel target discovery
Watch on-demand as PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji, to explore disease mechanisms and novel target discovery
Blog
Proving the power of combinatorial analytics
A summary of how >70% of associated novel gene targets for severe COVID-19 identified with combinatorial analytics in May 2020 have now been independently validated
Publication
Complexity of disease biology gives opportunities for drug discovery
In this article, Dr Steve Gardner, CEO PrecisionLife, examines the lack of return on investment for pharmaceutical R&D and the huge pockets of unmet medical need in common chronic disorders
Disease Study
Diabetes type 2 complications disease study
Developing combinatorial risk scores to accurately predict and prevent type 2 diabetes complications
Sign Up